# The Purpose of This Study is to Evaluate the Safety and Efficacy of Human TH-SC01 Cell Injection in the Treatment of Complex Perianal Fistula

> **NCT05677672** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Jiangsu Topcel-KH Pharmaceutical Co., Ltd.** · enrollment: 84 (estimated)

## Conditions studied

- Complex Perianal Fistulas

## Interventions

- **BIOLOGICAL:** Human TH-SC01 Cell Injection
- **OTHER:** Saline solution

## Key facts

- **NCT ID:** NCT05677672
- **Lead sponsor:** Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-30
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2023-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05677672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05677672, "The Purpose of This Study is to Evaluate the Safety and Efficacy of Human TH-SC01 Cell Injection in the Treatment of Complex Perianal Fistula". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05677672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*